There is mass effect with narrowing of the left lateral ventricle and third ventricle, as well as rightward midline shift
Originally developed under the brand name Ozempic for type 2 diabetes, it later received FDA approval as Wegovy at a higher dose specifically for chronic weight management
Published research on the individual peptides includes studies of: tendon biology ligament repair skeletal muscle connective tissue remodelling angiogense cicatrisation soft-tissue regeneration Because these research areas frequently overlap, combining BPC-157 and TB-500 into a single formulation has become a common approach in laboratory research
Proc Natl Acad Sci USA 93 : 83188323 Werner H, Le Roith D (2000) New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia
Wegovy (weight management): Weeks 1-4: 0.25 mg once weekly Weeks 5-8: 0.5 mg once weekly Weeks: 9-12: 1.0 mg once weekly Weeks 13-16: 1.7 mg once weekly if needed
liraglutide, dulaglutide, albiglutide and semaglutide)